The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Spanish Urological Association Registry of Patients on Active Surveillance
Official Title:
Study ID: NCT02865330
Brief Summary: Description: Multicentre observational study, not randomized. Ambispective character (retro and prospective). Opened to any member of the Asociación Española de Urología (AEU), public and private medicine. Justification: Active surveillance is a strategy proposed to control the overtreatment derived from the opportunist screening in prostate cancer (PCa). Its development in our country is erratic and different in every Center. This database tries to include most of patients included in active surveillance in Spain with a few minimal inclusion criteria. Multicentre registry and follow up of the active surveillance in Spain. Hypothesis: Mortality cancer specific for PCa includible in active surveillance to 15 years is lower than 5 %.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Instituto Valenciano de Oncología, Valencia, , Spain
Name: Jose Rubio Briones, MD, PhD
Affiliation: IVO
Role: PRINCIPAL_INVESTIGATOR
Name: Ángel Borque Fernando, MD, PhD
Affiliation: Hospital Miguel Servet
Role: PRINCIPAL_INVESTIGATOR